分子疾病与患病分子:本体论和认识论维度

Molecular diseases and diseased molecules: ontological and epistemological dimensions.

作者信息

Strasser B J, Fantini B

机构信息

Institute Louis-Jeantet for the History of Medicine, University of Geneva, Switzerland.

出版信息

Hist Philos Life Sci. 1998;20(2):189-214.

DOI:
Abstract

In 1949, Linus Pauling and collaborators published in Science a paper provocatively titled: 'Sickle cell anemia, a molecular disease'. What was actually meant by 'molecular disease'? We interpret the concept of molecular disease in the frame of the traditional positions about the nature of diseases, the ontological and the physiological positions. We conclude that the physiological does not give an adequate account of what molecular diseases are. The ontological position, when correctly reinterpreted, leads to an understanding of molecular diseases where the macromolecule is seen as a symptom or as a part of a mechanism leading to the symptoms of the disease. We then show that the concept of molecular disease leads to a particular view of therapy, emphasizing eugenics as a way of eliminating disease. On the individual level, this concept leads to an increased power of diagnosis, and especially predictive diagnosis, but has little therapeutic consequence. Lastly, we examine how this concept of disease unifies two contemporary classifications of diseases, one based on the location of the diseases, the other on the cause of the diseases.

摘要

1949年,莱纳斯·鲍林及其合作者在《科学》杂志上发表了一篇颇具争议的论文,标题为:“镰状细胞贫血,一种分子疾病”。“分子疾病”究竟是什么意思呢?我们在关于疾病本质的传统立场,即本体论立场和生理学立场的框架内解读分子疾病的概念。我们得出结论,生理学无法充分解释分子疾病是什么。本体论立场经过正确重新诠释后,能让人理解分子疾病,即把大分子视为一种症状或导致疾病症状的机制的一部分。然后我们表明,分子疾病的概念导致了一种特殊的治疗观点,强调优生学是消除疾病的一种方式。在个体层面,这个概念提高了诊断能力,尤其是预测性诊断能力,但对治疗影响不大。最后,我们研究了这种疾病概念如何统一两种当代疾病分类,一种基于疾病位置,另一种基于疾病病因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索